↓ Skip to main content

Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung

Overview of attention for article published in Frontiers in oncology, January 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung
Published in
Frontiers in oncology, January 2015
DOI 10.3389/fonc.2014.00376
Pubmed ID
Authors

Dawn Owen, Kenneth R. Olivier, Limin Song, Charles S. Mayo, Robert C. Miller, Kathryn Nelson, Heather Bauer, Paul D. Brown, Sean S. Park, Daniel J., Yolanda I. Garces

Abstract

Stereotactic body radiotherapy (SBRT) is commonly used to treat unresectable lung nodules. Given its relative safety and effective local control, SBRT has also been used to treat recurrent lung nodules after high-dose external beam radiation (EBRT) to the lung. The toxicity of such treatment is unknown.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 27%
Student > Ph. D. Student 4 27%
Student > Master 2 13%
Student > Bachelor 1 7%
Lecturer > Senior Lecturer 1 7%
Other 1 7%
Unknown 2 13%
Readers by discipline Count As %
Medicine and Dentistry 8 53%
Physics and Astronomy 1 7%
Agricultural and Biological Sciences 1 7%
Unknown 5 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 January 2015.
All research outputs
#22,760,732
of 25,374,917 outputs
Outputs from Frontiers in oncology
#15,919
of 22,416 outputs
Outputs of similar age
#308,452
of 361,109 outputs
Outputs of similar age from Frontiers in oncology
#85
of 99 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,416 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,109 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.